Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q3 2025

Type / Class
Equity / Common Stock, $0.001 par value
Symbol
LYRA on Nasdaq
Shares outstanding
1,644,695
Price per share
$0.09
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-300
Value change
-$26
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 1.1% $63,190 702,106 Nantahala Capital Management, LLC 30 Sep 2024
PERCEPTIVE ADVISORS LLC 16% $22,174 255,750 Perceptive Advisors LLC 12 Aug 2025

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA). This represents 0% of the company’s total 1,644,695 outstanding shares.

Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$26 $0.09 0
2025 Q2 300 $26 -$3,198,056 $0.09 1
2025 Q1 25,592,846 $3,229,183 -$198,660 $0.13 55
2024 Q4 26,880,629 $5,543,705 -$1,490,558 $0.21 52
2024 Q3 32,527,603 $8,360,258 -$117,730 $0.26 60
2024 Q2 32,730,111 $9,057,542 -$110,888,115 $0.28 50
2024 Q1 45,559,346 $283,375,342 +$20,623,317 $6.22 78
2023 Q4 16,737 $87,702 +$87,702 $5.24 1
2023 Q3 31,928,716 $124,842,063 -$8,075,975 $3.91 44
2023 Q2 33,698,803 $138,396,240 +$60,941,198 $4.11 38
2023 Q1 18,925,568 $38,103,347 -$235,866 $2.01 30
2022 Q4 19,073,085 $59,889,323 -$487,249 $3.14 34
2022 Q3 19,155,756 $95,971,150 -$622,456 $5.01 32
2022 Q2 19,268,307 $108,868,066 +$80,651,752 $5.65 31
2022 Q1 5,023,218 $20,194,830 -$472,028 $4.02 24
2021 Q4 5,050,150 $22,018,742 -$3,581,466 $4.36 30
2021 Q3 6,667,024 $60,849,825 -$2,869,071 $9.14 34
2021 Q2 6,863,681 $55,113,000 -$6,262,171 $8.02 37
2021 Q1 7,560,152 $87,618,000 -$11,847,478 $11.59 49
2020 Q4 8,595,912 $97,990,000 +$10,187,248 $11.40 43
2020 Q3 7,656,403 $85,729,000 +$6,831,952 $11.18 39
2020 Q2 7,037,339 $79,798,000 +$79,779,857 $11.34 43